BIOCONJUGATES OF NANOPARTICLES AS RADIOPHARMACEUTICALS
    21.
    发明公开
    BIOCONJUGATES OF NANOPARTICLES AS RADIOPHARMACEUTICALS 审中-公开
    纳米生物共轭如何RADIOPHARMACA

    公开(公告)号:EP1286705A2

    公开(公告)日:2003-03-05

    申请号:EP01941750.0

    申请日:2001-05-31

    CPC classification number: B82Y5/00 A61K47/6923 A61K51/1244 G02B2006/12195

    Abstract: A bioconjugate including a nonoparticle covatently linked to a biological vector molecule. The nanoparticle is a generally radiocative metal ion and most typically a metal oxide. The biological vector molecule is typically a monoclonal antibody or fragment of a monoclonal antibody or a peptide having a known affinity to cancer cells. One or more additional, different biological moieties may be covalently linked to the nanoparticle in addition to the biological moieties may be covalently activity. The bioconjugate of the present invention has utility as an effective radiopharmaceutical to deliver a radiolabel in tumor treatment.

Patent Agency Ranking